The problem with the Kaplan-Meier curve is that most of the time, they represents figures about the whole patient population, but depending on the disease, ther

The problem with the Kaplan-Meier curve is that most of the time, they represents figures about the whole patient population, but depending on the disease, there are extreme differences between stages and possibly dozens of cytogenetic factors. AML 5 year survival can be as low as ~15% and as high as ~70%. For Melanoma patients, it ranges between 100% (in situ) and 10% (stage IV).